Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e69098
Publisher
Public Library of Science (PLoS)
Online
2013-07-12
DOI
10.1371/journal.pone.0069098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples
- (2014) Federica Grillo et al. Translational Oncology
- Inhibition of gastric tumor growth by a novel Hsp90 inhibitor
- (2013) Chunwan Lu et al. BIOCHEMICAL PHARMACOLOGY
- Guidelines and considerations for conducting experiments using tissue microarrays
- (2013) Mohammad Ilyas et al. HISTOPATHOLOGY
- Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer
- (2013) Z. A. Wainberg et al. MOLECULAR CANCER THERAPEUTICS
- High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer
- (2013) Jiahong Wang et al. PLoS One
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- HER2/neuGene Amplification and Protein Overexpression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Review of Histopathology, Diagnostic Testing, and Clinical Implications
- (2012) Jaclyn F. Hechtman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
- (2012) David S. Hong et al. CANCER TREATMENT REVIEWS
- Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
- (2012) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting Hsp90--Who Benefits and Who Does Not
- (2012) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
- (2012) M. Terashima et al. CLINICAL CANCER RESEARCH
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
- (2012) Kohei Shitara et al. Gastric Cancer
- Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
- (2012) Eun Yoon Cho et al. MODERN PATHOLOGY
- HER2 testing in gastric cancer: a practical approach
- (2012) Josef Rüschoff et al. MODERN PATHOLOGY
- Losses of Chromosome 5q and 14q Are Associated with Favorable Clinical Outcome of Patients with Gastric Cancer
- (2012) T. E. Buffart et al. ONCOLOGIST
- HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature
- (2012) Jan Trøst Jørgensen et al. Journal of Cancer
- Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
- (2011) Xiangyi Lu et al. BIOCHEMICAL PHARMACOLOGY
- Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
- (2011) Komal Jhaveri et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
- (2011) Kyung-Hun Lee et al. CANCER SCIENCE
- Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers
- (2011) Naomi Ono et al. CANCER SCIENCE
- Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
- (2011) Jiyuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer
- (2011) Cristina Grávalos et al. Clinical & Translational Oncology
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment
- (2011) Judith Maresch et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment
- (2011) Hardik J Patel et al. Expert Opinion on Drug Discovery
- Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review
- (2011) Terence C. Chua et al. INTERNATIONAL JOURNAL OF CANCER
- Determining TrueHER2Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2Targeted Therapy
- (2011) Chun Hing Tse et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
- (2011) Rupert Langer et al. MODERN PATHOLOGY
- Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
- (2011) M. Scaltriti et al. MOLECULAR CANCER THERAPEUTICS
- Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17
- (2010) Semir Vranic et al. CANCER
- Targeting heat shock proteins in cancer
- (2010) Gaëtan Jego et al. CANCER LETTERS
- Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
- (2010) James R Porter et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Insights into designing the dual-targeted HER2/HSP90 inhibitors
- (2010) Chien-Yu Chen et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Classification of HER2/neu Status in Gastric Cancer Using a Breast-Cancer Derived Proteome Classifier
- (2010) Benjamin Balluff et al. JOURNAL OF PROTEOME RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Tissue Microarray for Routine Analysis of Breast Biomarkers in the Clinical Laboratory
- (2009) Thomas A. Thomson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival
- (2009) Constantinos Giaginis et al. BMC GASTROENTEROLOGY
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth
- (2009) S Chandarlapaty et al. ONCOGENE
- HER2+ Breast Cancer
- (2008) David G. Hicks et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search